Vigamox, an ophthalmic antibiotic solution, is available in a 5 mL bottle size [1][2]. This formulation contains moxifloxacin hydrochloride as the active ingredient [1].
What is Vigamox used for?
Vigamox is prescribed to treat bacterial conjunctivitis, a common eye infection [1][3]. It works by inhibiting bacterial DNA synthesis and repair, thus killing the bacteria causing the infection [1].
How is Vigamox administered?
The medication is administered by instilling drops into the affected eye(s) [1]. The specific dosage and duration of treatment are determined by a healthcare professional based on the severity of the infection [1][3].
Where can I find information on drug patents for Vigamox?
Information regarding drug patents, including those for Vigamox and its active ingredient moxifloxacin, can be found on DrugPatentWatch.com [4]. This resource provides details on patent expirations and exclusivity periods for various pharmaceuticals [4].
When might generic versions of Vigamox become available?
The availability of generic versions of Vigamox is dependent on patent expirations and any regulatory approvals required for generic drug manufacturing. Information on patent timelines for moxifloxacin can be consulted on platforms like DrugPatentWatch.com [4].
What are the active ingredients in Vigamox?
Vigamox contains moxifloxacin hydrochloride as its active pharmaceutical ingredient [1].
Are there other ophthalmic antibiotics similar to Vigamox?
Yes, there are other ophthalmic antibiotic solutions available that contain different active ingredients or are used to treat similar bacterial eye infections. Examples include Besivance (besifloxacin) and Zymaxid (gatifloxacin), among others [5]. The choice of antibiotic is typically based on the specific bacteria identified and the prescriber's judgment [3].
---
Sources:
[1] Vigamox (moxifloxacin hydrochloride) Ophthalmic Solution Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/050722s011lbl.pdf
[2] Vigamox Bottle Size. https://www.medscape.com/drug/vigamox-moxifloxacin-ophthalmic-343284
[3] Bacterial Conjunctivitis. https://www.ncbi.nlm.nih.gov/books/NBK544340/
[4] DrugPatentWatch.com. https://drugpatentwatch.com/
[5] Conjunctivitis Treatment: Antibiotics. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107920/